SEC Form 4 · accession 0001140361-15-019203
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2015 | F | 5,479 | $121.66 | D | 243,175 | D | |
| Common Stock | holding | — | — | — | 33,258 | I | Shares held by Bienaime Family Trust |
Table II — derivative securities
No Table II lines on this filing.